We present a case of a patient who received adjunct treatment with a self-expanding stent after balloon dilatation of a symptomatic stenosis of the carotid siphon.
After predilatation, complementary angioplasty with a balloon-expandable stent was abolished due to lack of compliance of the delivery system. Since the vascular anatomy allows for the passage of balloon systems only, the stenosis was further dilated and a self-expanding stent was delivered to avoid the risk of complications related to dissection and vessel recoil. However, problem of in-stent stenosis remains at the long-term follow-up period.
TanakaHSukhovaGK: Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation88: 1788–1803, 1993.
4.
WainwrightCLMillerAMWadsworthRM: Inflammation as a key event in the development of neointima following vascular balloon injury. Clin Exp Pharmacol Physiol28: 891–895, 2001.
GomezCRMirsaVK: Elective stenting of symptomatic middle cerebral artery stenosis. Am J Neuroradiol21: 971–973, 2000.
7.
LylykPCohenJE: Angioplasty and stent placement in intracranial atherosclerotic stenosis and dissections. Am J Neuroradiol23: 430–436, 2002.
8.
MoriTKazitaK: Short-term arteriographic and clinical outcome after cerebral angioplasty and stenting for intracranial vertebrobasilar and carotid atherosclerotic occlusive disease. Am J Neuroradiol21: 249–254, 2000.
9.
de RochemontRMTurowskiB: Recurrent symptomatic high-grade intracranial stenosis: safety and efficacy of undersized stents - initial experience. Radiology231: 45–49, 2004.
10.
FiorellaDAlbuquerqueFC: Preliminary experience using the Neuroform stent for the treatment of cerebral aneurysms. Neurosurgery54: 6–17, 2004.
11.
HowingtonJUHanelRA: The Neuroform stent, the first microcatheter-delivered stent for use in the intracranial circulation. Neurosurgery54: 2–5, 2004.
12.
ChimowitzMIKokkinosP: The warfarin-aspirin symptomatic intracranial disease study. Neurology45: 1488–1493, 1995.
13.
The warfarin-aspirin symptomatic intracranial disease (WASID) study group: Prognosis of patients with symptomatic vertebral or basilar artery stenosis. Stroke29: 1389–1392, 1998.
14.
ThijsVNAlbersGW: Symptomatic intracranial atherosclerosis-Outcome of patients who fail antithrombotic therapy. Neurology55: 490–497, 2000.
15.
SSYLVIA Study Investigators: Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA) study results. Stroke35: 1388–1392, 2004.
16.
QureshiAILuftAR: Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures. I. Pathophysiological and pharmacological features. Neurosurgery46: 1344–1359, 2000.
17.
FiorellaDAlbuquerqueFC: In-stent stenosis as a delayed complication of Neuroform stent-supported coil embolization of an incidental carotid terminus aneurysm. Am J Neuroradiol25: 1764–1767, 2004.
18.
LopesDSaniS: Histological postmortem study of an internal carotid artery aneurysm treated with the Neuroform stent. Neurosrugery56: E416, 2005.
